Pitar Pharmaceuticals And Marketing Limi Ted Profile
Key Indicators
- Authorised Capital ₹ 0.54 M
as on 25-05-2024
- Paid Up Capital ₹ 0.54 M
as on 25-05-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Pitar Pharmaceuticals And Marketing Limi Ted
The Corporate was formerly known as Pitar Pharmaceuticals And Marketing Limi Ted. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.54 M and a paid-up capital of Rs 0.54 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Sharma, Rashmi Jindal, and Rakesh Kumar serve as directors at the Company.
- CIN/LLPIN
U24232RJ2010PLC031261
- Company No.
031261
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pitar Pharmaceuticals And Marketing Limi Ted?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Sharma  | Director | 31-Oct-2019 | Current |
| Rashmi Jindal | Director | 02-Jun-2017 | Current |
| Rakesh Kumar | Director | 02-Jun-2017 | Current |
Financial Performance and Corporate Structure Insights of Pitar Pharmaceuticals And Marketing Limi Ted.
Pitar Pharmaceuticals And Marketing Limi Ted, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pitar Pharmaceuticals And Marketing Limi Ted?
In 2017, Pitar Pharmaceuticals And Marketing Limi Ted had a promoter holding of 65.93% and a public holding of 34.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shivam Propcon LimitedActive 16 years 10 monthsRajesh Sharma, Rashmi Jindal and 1 more are mutual person
- Green Royal Tradelink LimitedActive 14 years 2 months
Rajesh Sharma, Rashmi Jindal and 1 more are mutual person
- Toshi Cargo LimitedActive 13 years 9 months
Rajesh Sharma, Rashmi Jindal and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pitar Pharmaceuticals And Marketing Limi Ted?
Unlock and access historical data on people associated with Pitar Pharmaceuticals And Marketing Limi Ted, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pitar Pharmaceuticals And Marketing Limi Ted, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pitar Pharmaceuticals And Marketing Limi Ted's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
